Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation
This study elucidated the optimal tacrolimus trough level and highlighted the impact of IPV on the CKD and ESRD development post-LT.
Authors
- Young Kyoung You
- Pil Soo Sung (ORCID: https://orcid.org/0000-0002-5780-9607)
- Jeong Won Jang (ORCID: https://orcid.org/0000-0003-3255-8474)
- Soon Kyu Lee (ORCID: https://orcid.org/0000-0003-1865-8225)
- Seung Kew Yoon (ORCID: https://orcid.org/0000-0002-4476-4868)
- Jong Young Choi (ORCID: https://orcid.org/0000-0001-7833-0307)
- Ho Joong Choi (ORCID: https://orcid.org/0000-0002-0862-098X)
Institutions
- St. Mary's Hospital (US)
- The Catholic University of Korea Incheon St. Mary's Hospital (KR)
- St Mary's Hospital (GB)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Clinical and Molecular Hepatology
- Published
- 2024-10-02
- DOI
- https://doi.org/10.3350/cmh.2024.0451
- Citations
- 6
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.05
Funders
- National Research Foundation
- Catholic University of Korea
- Ministry of Trade, Industry and Energy
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
- Incheon St. Mary's Hospital, Catholic University of Korea